by secretary@indianrheumatology.org | Aug 8, 2024 | March 2024
Juvenile spondyloarthrits: Is it the same as adult spondyloarthritis? Deepti Suri MD, DNBProfessor of Paediatric Allergy and ImmunologyAdvanced Paediatrics Centre, Postgraduate Institute of Medical Education and Research,Chandigarh The spondyloarthropathies (SpAs) are...
by secretary@indianrheumatology.org | Aug 8, 2024 | March 2024
Multiple dimensions of spondyloarthritis: an enigma for rheumatologists Karl Gaffney FRCPConsultant Rheumatologist, Norfolk and Norwich University Hospital, Norwich, UKHonorary Professor, Norwich Medical School, Chair, British Society for Spondyloarthritis, Chair, BSR...
by secretary@indianrheumatology.org | Aug 8, 2024 | March 2024
Epidemiology of Arthritis in India – A Personal Perspective Arvind Chopra MD, DNB, FRCP (London), Master American College of RheumatologyDirector and Chief Rheumatologist, Centre for Rheumatic Diseases, Pune What made you interested in epidemiological research? During...
by secretary@indianrheumatology.org | Aug 8, 2024 | March 2024
Quarter in review – Basic science Taral P Parikh MD, DNB RheumatologyConsultant Rheumatologist, Zydus Hospital/ Rheumacare Clinic,Ahmedabad Study in focus 1: Proteomic and genomic profiling of plasma exosomes from patients with Ankylosing spondylitis (AS)1. Study...
by secretary@indianrheumatology.org | Aug 8, 2024 | March 2024
Quarter in review: Clinical Sciences Preksha Dwivedi MD, DMAssociate Professor, Department of Medicine, Gandhi Medical College, Bhopal Study in focus 1: Bimekizumab treatment in biologic DMARD-naïve patients with active psoriatic arthritis: long term efficacy and...
